Disclosure under Regulation 7(2) of SEBI (PIT) Regulations, 2015 - Informatioin and Update

Date: October 01, 2026 To, To, National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1 Block G, 25th Floor, Bandra Kurla Complex Phiroze Jeejeebhoy Towers, Bandra [E], Dalal Street, Fort, Mumbai – 400051 Mumbai - 400 001 NSE Scrip Symbol: KRONOX BSE Scrip Code: 544187 Sub.: Disclosure as per Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 Dear Sir / Madam, Pursuant to Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended (‘PIT’ Regulations) we are enclosing herewith a disclosure received by Kronox Lab Sciences Limited (“Company”)) under Regulations 7(2)(a) of PIT Regulation from Mr. Jogindersingh Jaswal, in Form B, in relation to the sale of 9796400 Equity Shares of the Company held by him, representing approximately 23.09% of the Total Paid up Equity share Capital of the Company. We request you to kindly take the above disclosure on your record. Thanking You, Yours Faithfully, For KRONOX LAB SCIENCES LIMITED Nikhil Goswami Company Secretary & Compliance O(cid:431)icer M. No. A68272 Encl.: Form B received from Mr. Jogindersingh Jaswal. Date: October 01, 2026 To, To, National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1 Block G, 25th Floor, Bandra Kurla Complex Phiroze Jeejeebhoy Towers, Bandra [E], Dalal Street, Fort, Mumbai – 400051 Mumbai - 400 001 NSE Scrip Symbol: KRONOX BSE Scrip Code: 544187 Sub.: Disclosure as per Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 Dear Sir / Madam, Pursuant to Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended (‘PIT’ Regulations) we are enclosing herewith a disclosure received by Kronox Lab Sciences Limited (“Company”) under Regulations 7(2)(a) of PIT Regulation from Mr. Ketan Ramani, in Form B, in relation to the sale of 9796400 Equity Shares of the Company held by him, representing approximately 23.09% of the Total Paid up Equity share Capital of the Company. We request you to kindly take the above disclosure on your record. Thanking You, Yours Faithfully, For KRONOX LAB SCIENCES LIMITED Nikhil Goswami Company Secretary & Compliance O(cid:431)icer M. No. A68272 Encl.: Form B received from Mr. Ketan Ramani Date: October 01, 2026 To, To, National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1 Block G, 25th Floor, Bandra Kurla Complex Phiroze Jeejeebhoy Towers, Bandra [E], Dalal Street, Fort, Mumbai – 400051 Mumbai - 400 001 NSE Scrip Symbol: KRONOX BSE Scrip Code: 544187 Sub.: Disclosure as per Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 Dear Sir / Madam, Pursuant to Regulation 7(2)(b) of SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended (‘PIT’ Regulations) we are enclosing herewith a disclosure received by Kronox Lab Sciences Limited (“Company”) under Regulations 7(2)(a) of PIT Regulation from Mr. Pritesh Ramani, in Form B, in relation to the sale of 6711200 Equity Shares of the Company held by him, representing approximately 18.09% of the Total Paid up Equity share Capital of the Company. We request you to kindly take the above disclosure on your record. Thanking You, Yours Faithfully, For KRONOX LAB SCIENCES LIMITED Nikhil Goswami Company Secretary & Compliance O(cid:431)icer M. No. A68272 Encl.: Form B received from Mr. Pritesh Ramani